FibroBiologics, Inc. (FBLG)Healthcare | Biotechnology | Houston, United States | NasdaqCM
1.44 USD
-0.05
(-3.356%) ⇩
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 1.42 -0.02 (-0.020%) ⇩ (Aug. 28, 2026, 7:30 p.m. EDT) |
Hot Take ↕ | Aug. 22, 2026, 2:37 a.m. EDT
The immediate outlook is clouded by severe structural distress rather than investment opportunity. The company is actively fighting to avoid delisting from Nasdaq, having just announced a reverse stock split to regain compliance with bid price requirements while simultaneously appealing a delisting move. This regulatory precariousness, combined with a massive 58% drop in share price over the last year and a history of negative free cash flow and losses, suggests a high probability of further volatility or a liquidity event rather than a recovery. While the recent price action shows a temporary bounce off the lows, the underlying business fundamentals—negative returns on equity and assets, and no analyst consensus—do not support a bullish thesis. There is no dividend income to offset these risks. Investors should view this as a speculative gamble on a turnaround that faces significant hurdles, not a standard equity investment. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.540748 |
| MSTL | 0.612507 |
| AutoETS | 0.624380 |
| AutoARIMA | 0.631373 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 29% |
| H-stat | 14.72 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.059 |
| Excess Kurtosis | -0.91 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 31.536 |
| Market Cap | 9,587,798 |
| Forward P/E | -0.44 |
| Beta | 1.22 |
| Website | https://fibrobiologics.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.8800322 |
| Address1 | 455 East Medical Center Boulevard |
| Address2 | Suite 300 |
| All Time High | 1,100.0 |
| All Time Low | 0.62 |
| Ask | 1.46 |
| Ask Size | 1 |
| Average Daily Volume10 Day | 280,400 |
| Average Daily Volume3 Month | 179,377 |
| Average Volume | 179,377 |
| Average Volume10Days | 280,400 |
| Beta | 1.218 |
| Bid | 1.0 |
| Bid Size | 7 |
| Book Value | 0.762 |
| City | Houston |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 1.44 |
| Current Ratio | 2.643 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 1.54 |
| Day Low | 1.415 |
| Debt To Equity | 31.536 |
| Display Name | FibroBiologics |
| Earnings Timestamp End | 1,755,201,600 |
| Earnings Timestamp Start | 1,755,201,600 |
| Ebitda | -16,466,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -0.458 |
| Enterprise Value | 7,534,798 |
| Eps Current Year | -3.0 |
| Eps Forward | -3.25 |
| Eps Trailing Twelve Months | -4.93 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 0.92284 |
| Fifty Day Average Change | 0.51716006 |
| Fifty Day Average Change Percent | 0.56040055 |
| Fifty Two Week Change Percent | -88.00322 |
| Fifty Two Week High | 12.56 |
| Fifty Two Week High Change | -11.120001 |
| Fifty Two Week High Change Percent | -0.88535035 |
| Fifty Two Week Low | 0.62 |
| Fifty Two Week Low Change | 0.82000005 |
| Fifty Two Week Low Change Percent | 1.3225807 |
| Fifty Two Week Range | 0.62 - 12.56 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,706,711,400,000 |
| Float Shares | 6,001,096 |
| Forward Eps | -3.25 |
| Forward P E | -0.44307694 |
| Free Cashflow | -8,368,000 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 15 |
| Fullday Change | -0.05 |
| Fullday Change Percent | -3.3557 |
| Fullday Price | 1.42 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.09869 |
| Held Percent Institutions | 0.15533 |
| Implied Shares Outstanding | 6,658,193 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Ipo Expected Date | 2,024-01-31 |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,774,828,800 |
| Last Split Factor | 1:20 |
| Long Business Summary | FibroBiologics, Inc., a clinical-stage biotechnology company, engages in the development and commercialization of fibroblast-based therapies for patients suffering from chronic diseases. The company's product pipeline includes CYWC628 which has completed pre-clinical trial for the treatment of wound healing; CYMS101 which has completed Phase 1 trial for the treatment of multiple sclerosis; CybroCell for the treatment of degenerative disc disease; and CYPS317 for the treatment of psoriasis. It also develops early-stage research products, including CYTER915 to treat the human longevity; and TCB190 for the treatment of certain cancers. FibroBiologics, Inc. was incorporated in 2021 and is headquartered in Houston, Texas. |
| Long Name | FibroBiologics, Inc. |
| Market | us_market |
| Market Cap | 9,587,798 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_1758633149 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | -18,139,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 9,920,707 |
| Number Of Analyst Opinions | 2 |
| Open | 1.5 |
| Operating Cashflow | -14,790,000 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | 281 671 5150 |
| Post Market Change | -0.0200001 |
| Post Market Change Percent | -1.3888958 |
| Post Market Price | 1.42 |
| Post Market Time | 1,787,959,806 |
| Previous Close | 1.49 |
| Price Eps Current Year | -0.48000002 |
| Price Hint | 4 |
| Price To Book | 1.8897638 |
| Profit Margins | 0.0 |
| Quick Ratio | 1.588 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.05 |
| Regular Market Change Percent | -3.3557 |
| Regular Market Day High | 1.54 |
| Regular Market Day Low | 1.415 |
| Regular Market Day Range | 1.415 - 1.54 |
| Regular Market Open | 1.5 |
| Regular Market Previous Close | 1.49 |
| Regular Market Price | 1.44 |
| Regular Market Time | 1,787,947,201 |
| Regular Market Volume | 143,715 |
| Return On Assets | -0.95765 |
| Return On Equity | -6.6008 |
| Sand P52 Week Change | 0.20504117 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 6,658,193 |
| Shares Percent Shares Out | 0.021300001 |
| Shares Short | 141,714 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 70,837 |
| Short Name | FibroBiologics, Inc. |
| Short Percent Of Float | 0.0224 |
| Short Ratio | 0.93 |
| Source Interval | 15 |
| State | TX |
| Symbol | FBLG |
| Target High Price | 19.0 |
| Target Low Price | 6.0 |
| Target Mean Price | 12.5 |
| Target Median Price | 12.5 |
| Total Cash | 3,515,000 |
| Total Cash Per Share | 0.528 |
| Total Debt | 1,462,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -4.93 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 3.41217 |
| Two Hundred Day Average Change | -1.9721699 |
| Two Hundred Day Average Change Percent | -0.5779811 |
| Type Disp | Equity |
| Volume | 143,715 |
| Website | https://fibrobiologics.com |
| Zip | 77,598 |